NDC 80425-0199-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0199
- Requested NDC
- 80425-0199-01
- Package NDCs from labels
- 80425-0199-2, 80425-0199-3, 80425-0199-1, 80425-0199-4, 80425-0199-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0199-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 | |
| 80425-0199-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 5 | |
| 80425-0199-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 5 | |
| 80425-0199-4 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0199 | GABAPENTIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250101_ec1c621b-db2a-1567-e053-2995a90a8695.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0199-1 | EA - Each | 80425-0199 | d68dc437-0849-41c2-b17b-257d12f6b61c | 1 | 2023-06-06 |
| 80425-0199-2 | EA - Each | 80425-0199 | 72852c7a-f605-4712-bd72-41cd7fab8078 | 1 | 2023-06-06 |
| 80425-0199-3 | EA - Each | 80425-0199 | d088f4ae-c84a-47de-954a-d5659921b2bf | 1 | 2023-06-06 |
| 80425-0199-4 | EA - Each | 80425-0199 | 23d7cfee-4b7b-41a1-a066-247e8cdd763e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Epic Pharma, LLC | 030e656a-e384-49ac-830f-32140c18112d | 2019-01-07 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | a900bafb-8f49-4a01-ba7f-4fb228ec0253 | 2018-11-12 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 6702ed8f-4aaf-46fa-bf39-db75154aa44c | 2018-10-19 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 1b73e9db-eddb-49ba-9778-01d39ece4d16 | 2018-09-21 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | f455b415-12a2-4916-b826-246976a8af44 | 2018-09-12 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 5fbd601f-df95-4a79-a7d3-c3505e23b913 | 2018-09-06 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 9d1b9121-c25a-4d28-91c5-5fc72f1167f4 | 2018-07-12 | 310431 6CW7F3G59X | |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 37d4d465-19a5-46db-80dc-0b7334b3343a | 2018-06-25 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 6fc8e8b2-5d0e-4c72-9a46-6d312c3efac7 | 2018-05-14 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 86b30e64-fe56-42b3-a0f8-d9ef5d4b8c49 | 2016-06-20 | Warnings, Adverse reactions | 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bi-Coastal Pharma International LLC | e0cd96d1-b1ef-46ec-a5a3-9505b0811b8b | 2016-04-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.